Ligatio Group

Revolution in Orthopedic and Dental Materials

Product Offerings

Company Overview:

Ligatio Group is a rapidly growing technology holding company specializing in innovative material solutions for the orthopedic market and 3D dental printing. Our technologies and products cater to the growing needs of B2B clients, including dental clinics, prosthetic laboratories, and orthopedic units. Our solutions fully optimize the working time of specialists, as exemplified by the 5-minute application of Poliwater bandages compared to over 25 minutes for traditional plaster casts..

Product Offerings:

An innovative, reimbursable synthetic plaster in the form of a lattice sleeve for limb immobilization. It is lightweight, waterproof, breathable, and X-ray transparent, with a 5-minute application time.

Market Entry Readiness: Q3 2024

The world’s first synthetic plaster for limb immobilization, cured with UV light, enabling the conservative treatment of displaced fractures. (Patent Application: PCT/IB2023/052525)

Market Entry Readiness: Q2 2025

Advanced Class I and IIa dental resins for 3D printing, and a device for coloring according to the patient’s tooth shade. We reduce the working time for dentists and laboratories by up to five times and lower production costs. (Patent Application: 23461685.2-1017)

Market Entry Readiness: On the market; Model One, Class I: Q3 2025

Seed Round and Shareholding Structure:

N

Required Funds: PLN 16 million

N

Before Seed Round: Founders – 80%

N

After Seed Round: Founders – 60%

N

New Investors: 20%

N

ESOP (for staff): 10%

N

Pre-seed Investor (Scanderia Venture): 13% post-dilution

Planned Expenditures:

N

Salaries and Marketing: PLN 8 million

N

Capex, Certification, and Fixed Costs: PLN 8 million

Investment Expenditures Linked to Achievable Revenues:

Expenditures – PLN 1.93 million;

Revenue – PLN 8.42 million

Expenditures – PLN 1.81 million

Revenue – PLN 2.30 million

Expenditures – PLN 0.58 million;

Revenue – PLN 4.17 million

Orthopedics:

$

Global: 356 million fractures, dislocations, and sprains annually

$

Poland: approx. 700,000 patients annually

$

CAGR: 6.7%

$

Healthcare Spending Growth in Poland: 2021 vs. 2016 increase by 83% (PLN 67 billion)

$

Target B2B Clients: Orthopedic clinics, public hospitals, emergency rooms (240)

Dentistry:

$

Global: 100 million crowns annually approx. 40%
of dental laboratories in the EU use 3D printing

$

CAGR: 21.3% **Growing patient demand for same-day crown
replacements instead of a one-week wait

$

Target B2B Clients: Dental laboratories
(approx. 4000), Dental clinics

Investment Thesis

Multi-technology holding:

Leader in the growing orthopedic and dental markets.Nulla porttitor accumsan tincidunt. Donec rutrum congue leo

Reimbursement:

Full reimbursement capability in Poland with potential for
European and NorthAmerican markets.

Expected exit opportunity:

Potential for M&A or SPA within  5  years.

Break-even Point:

2027

Addressing premium B2B clients:

Clinics, laboratories, and research institutes.

Strong IP and team:

Intellectual property protection and experienced personnel.

Highest standards:

Our medical products meet the standards developed according to ISO 9001, ISO 13485, and MDR norms.

Growth strategy:

Effective development and technology readiness strategy, with planned  PLN 33  million.